| Literature DB >> 32198423 |
Santos Villafaina1, Daniel Collado-Mateo2, Francisco J Domínguez-Muñoz1, Narcis Gusi1, Juan P Fuentes-Garcia3.
Abstract
The objective of the present manuscript was to evaluate the effects of 24-weeks exergame intervention on the heart rate variability (HRV) of women with fibromyalgia. First, 56 women with fibromyalgia were assessed for eligibility. A total of 55 women fulfilled the inclusion criteria and participated in this single-blinded, randomized controlled trial. A 24-weeks of exergames were completed by the exercise group in the university facilities. It was focused on the mobility, postural control, upper and lower limbs coordination, aerobic fitness and strength. A total of 120 min per week, divided into two sessions of 60 min, was completed. A short-term 5 min record at rest was used to assess the HRV. Time (SDNN and RMSSD) and non-linear indexes (Higuchi´s Fractal Dimension, SD1, SD2, ln stress score, and SD1/SD2) of HRV were extracted. Fifty participants (achieving an 89.28% of adherence), recruited from the local fibromyalgia association completed the study. They were randomly divided into an exercise (age = 54.04[8.45]) and a control group (52.72[9.98]). Significant interaction (group*time) effects in SDNN, ln stress score, SD2, and SD1/SD2 ratio were found. The EG showed an increase of SDNN and a decreased ln stress score and SD2. The CG showed an increased ln stress score, SD1/SD2. In conclusion, 24-weeks of exergame intervention based on the tool VirtualEx-FM improved the autonomic control in patients with fibromyalgia. However, significant effects on Higuchi´s fractal dimension were not found. This is the first study using exergame as a therapy in women with fibromyalgia which has led to an improvement the autonomic balance in these patients.Entities:
Mesh:
Year: 2020 PMID: 32198423 PMCID: PMC7083950 DOI: 10.1038/s41598-020-61617-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of the participants.
Demographic data and differences between groups at baseline.
| Variable | Exercise Group Mean (SD) | Control Group Mean (SD) | Value of Contrast | p-valuea |
|---|---|---|---|---|
| Sample size | 28 | 27 | ||
| Age (years) | 54.04 (9.96) | 53.41 (9.92) | 0.234 | 0.816 |
| SDNN (ms) | 22.98 (8.12) | 26.61 (10.28) | −1.455 | 0.152 |
| RMMSD (ms) | 21.18 (10.51) | 22.97 (12.88) | −0.565 | 0.574 |
| ln Stress Score | 3.61 (0.33) | 3.47 (0.44) | 1.261 | 0.213 |
| SD1 (ms) | 15.01 (7.44) | 16.26 (9.12) | −0.561 | 0.577 |
| SD2 (ms) | 28.55 (9.49) | 33.59 (12.39) | −1.697 | 0.096 |
| SD1/SD2 | 0.52 (0.15) | 0.47 (0.16) | 1.251 | 0.216 |
| HFD | 1.33 (0.12) | 1.37 (0.12) | −0.915 | 0.365 |
ap-values of t-test for independent sample to compare differences between groups at baseline.
SDNN: standard deviation of all normal to normal RR intervals; ln stress score: natural logarithm of the 1000*1/SD2; SD1: standard deviation of points perpendicular to the axis of line-of-identity in the Poincaré plot; SD2: standard deviation, of points along the axis of line-of-identity in the Poincaré plot; SD1/SD2: ratio between SD1 and SD2; HFD: Higuchi Fractal Dimension.
Surrogate data test analysis of the RR time series.
| Non linearity assumed n (%) | |||
|---|---|---|---|
| Pre | Post | ||
| Surrogate data test | Exercise | 12 (48%) | 14 (56%) |
| Control | 12 (48%) | 11 (44%) | |
| p-value | 1.000 | 0.720 | |
ap-values obtained from chi-square test.
Efficacy analysis of exergame intervention in the HRV indexes in patients with fibromyalgia.
| Heart rate variability indexes | Pre | Post | Within Group Comparison | Between Group Comparison | |||||
|---|---|---|---|---|---|---|---|---|---|
| Value of the contrast | P-value | Effect Size | F | P-valuea | Effect Size | ||||
| SDNN (ms) | Exercise | 23.59 (8.38) | 28.37 (13.83) | −2.454 | 0.022 | −0.368 | 6.262 | 0.016 | 0.721 |
| Control | 25.64 (10.06) | 20.97 (12.28) | 1.443 | 0.162 | 0.415 | ||||
| RMSSD (ms) | Exercise | 21.56 (11.06) | 24.28 (16.97) | −0.806 | 0.428 | −0.333 | 0.592 | 0.446 | 0.220 |
| Control | 21.07 (11.11) | 20.14 (14.36) | 0.280 | 0.782 | 0.073 | ||||
| ln Stress Score | Exercise | 3.58 (0.33) | 3.42 (0.42) | 3.119 | 0.005 | 0.414 | 7.739 | 0.008 | 0.804 |
| Control | 3.50 (0.45) | 3.83 (0.66) | −1.950 | 0.063 | −0.587 | ||||
| SD1 (ms) | Exercise | 15.27 (7.83) | 17.20 (12.01) | −0.807 | 0.428 | −0.187 | 0.593 | 0.445 | 0.220 |
| Control | 14.92 (7.87) | 14.26 (10.17) | 0.279 | 0.783 | 0.072 | ||||
| SD2 (ms) | Exercise | 29.37 (9.73) | 35.86 (16.36) | −3.124 | 0.005 | −0.395 | 9.024 | 0.004 | 0.866 |
| Control | 32.82 (12.55) | 25.77 (14.49) | 1.763 | 0.091 | 0.520 | ||||
| SD1/SD2 | Exercise | 0.52 (0.16) | 0.46 (0.17) | 1.224 | 0.233 | 0.351 | 6.897 | 0.012 | 0.759 |
| Control | 0.44 (0.13) | 0.54 (0.14) | −2.748 | 0.011 | −0.687 | ||||
| HFD | Exercise | 1.33 (0.12) | 1.34 (0.15) | −0.132 | 0.896 | −0.034 | 1.010 | 0.320 | 0.293 |
| Control | 1.37 (0.12) | 1.32 (0.11) | 1.250 | 0.224 | −0.320 | ||||